International biotech company dedicated to improving the lives of people with cancer & other serious diseases through antibodies. gmab.ly/Jn0e50XWplA

Joined December 2015
939 Photos and videos
#NewsUpdate: We shared results on one of our assets from two studies developed with @abbvie, in patients with newly diagnosed diffuse large B-cell #lymphoma at #EHA2026 Learn more: gmab.ly/iXO850Z7jy0
1
2
347
Jun 11
Today, we shared data evaluating one of our medicines used in a combination regimen for patients with relapsed/refractory follicular #lymphoma, developed with @abbvie. Learn more: gmab.ly/rMjn50Z7jIU #EHA2026
1
242
Jun 10
During this edition of #AntibodyHour 🕙, hear from Vilmarie Rodriguez, VP of Patient Assistance & Community Engagement at @CancerCare who shares about Cancer Care’s work in developing programs for patients through counseling, support groups and patient advocacy. She shares how she has found purpose in helping others. Her mission inspires us at Genmab as we move with the ambition to transform the lives of people living with cancer through innovative antibody medicines. #PatientFirst
2
3
762
Jun 8
We’re excited to share the latest from our #hematology research at #EHA26! Join us at the European Hematology Association’s Congress to explore how we’re advancing antibody science with the ambition to transform patients’ lives. Visit us at location B3.03 and learn more here: bit.ly/43lvdBO. #Oncology #Biotech
2
3
676
Jun 3
Non-Hodgkin #lymphoma (NHL) develops in the lymphatic system, affecting certain types of white blood cells. #ASCO2026 #EHA2026
4
365
May 29
At #ASCO2026, we continued our tradition of bringing together our patient advocacy organizations and professional societies to kick off ASCO with connection, dialogue, and shared purpose. Thank you to the leaders who spent time with us. Your perspectives and continued advocacy help guide how we think, collaborate, and work toward more patient-centered approaches. #PatientAdvocacy
2
5
896
May 27
During this edition of #AntibodyHour 🕙, patient advisor Linda Emery shares her experience and encourages others to see clinical trials differently; not as a final option but as an opportunity worth exploring. Her story is a reminder during Clinical Trial Awareness month of the importance of awareness and understanding the potential of clinical research. Learn more about our impact: genmab.com/patients-care-par… #Innovation #PatientFirst #ClinicalTrialAwarenessMonth
4
6
732
May 21
#NewsUpdate: We’re looking forward to presenting new data in #BloodCancer at #ASCO2026 and #EHA2026, with 20 abstracts showcasing our latest investigational treatment innovations across a range of B-cell malignancies. Learn more: gmab.ly/Qq7G50Z1MsW
2
5
760
May 8
By 2050, #ovariancancer diagnoses are projected to rise by more than 55%, impacting over half a million women globally (1). On #WorldOvarianCancerDay, we stand with the global community to drive awareness, earlier diagnosis, and improved care. 1 Global Cancer Observatory (GCO). International Agency for Research on Cancer, World Health Organization. Estimated numbers from 2022 to 2050, females aged 0–85 .
2
5
290
May 7
#InvestorUpdate: Genmab has published its first-quarter interim report. Hear from our executive leaders about the progress we have made in our late-stage pipeline of innovative antibody products and key business milestones achieved this quarter. Learn More: lnkd.in/e-wjdjCm. #Innovation #Biotech
1
4
642
May 7
Genmab is proud to support the next generation of life-science innovators by sponsoring the Life Science Award at the Danish Entrepreneurship Championship. Congrats to this year’s winners SundtGear, who created supportive tights with built-in elastic assist to help elderly users stand up safely. Learn more about how we support our community here: genmab.com/our-impact/corpor…. #LifeScience #Entrepreneurship
2
3
337
Apr 27
Recently, we celebrated our colleagues Amy Whited, Mande Ye, and Laura Højland Larsen who were recognized by @HBAnet as Luminaries and Rising Star at the Woman of the Year event! We congratulate you and thank you for your leadership and impact. #HBAWOTY2025
2
317
Apr 23
Our U.S. based colleagues celebrated #TakeYourChildToWorkDay by welcoming very special guests to Genmab for a day of discovery and learning about finance through a bake sale, making picture frames for children coping with the loss of a parent, building bee boxes to support sustainability, as well as participating in engaging sessions on brand marketing, AI and pathology. We loved sharing what we do, and why it matters with the next generation.
1
2
389
Apr 21
Head and neck squamous cell carcinoma (HNSCC) can be challenging to treat and can profoundly affect everyday activities, including speaking, swallowing, and interacting with others (1). That’s why awareness, education, and collaboration matter for people living with the disease. Genmab stands with the community and partners working to close gaps in awareness and care. #HeadandNeckCancerAwareness 1 McCartney J. Rising incidence of head and neck cancer drives treatment advances. Bull Am Coll Surg. October 2025;110(9). facs.org/for-medical-profess…
1
2
777
Apr 16
For many, the fight against head and neck cancer begins with uncertainty and can have profound impacts on daily life. Clear information, compassionate care, and strong support can make a real difference. Genmab is proud to stand with patients, care partners, and advocates to develop innovative antibody-based medicines in areas of critical need. #HeadandNeckCancerAwareness #HNSCC
3
355
Apr 15
What does it mean to lead with vision, drive innovation, and move faster for patients who can’t wait? Real innovation means challenging convention, embracing new ideas, and collaborating with the ambition to deliver meaningful progress for patients. Learn what our colleagues have to say about turning these ideas into action. Thanks to @BioNJ for the original footage produced by @KenBlando at Pulse Productions Inc. #Leadership #Innovation
1
2
4
358
Apr 13
At #SGO2026, we shared new safety data supporting the combination potential of one of our investigational agents in recurrent #OvarianCancer. Results add to the growing body of clinical evidence for this program and its potential to expand treatment options for patients. Visit: ir.genmab.com/genmab-news.
2
5
429
Apr 9
From bold antibody discovery to breakthrough innovation — this is Genmab. Learn how we’ve evolved from designing next-generation antibodies to taking greater ownership of their journey from discovery, through development, and all the way to the patients who need them most. Watch the full video to see how we’re leading antibody science for better futures here: lnkd.in/eXxuYjYk. #AntibodyScience
2
380